{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:47:19Z","timestamp":1777103239369,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Poorly differentiated neuroendocrine carcinoma (PDNEC) of the rectum and anus is a rare disease exhibiting aggressive biological behaviour, even if diagnosed early. Currently, there are no agreed standard treatment approaches and management of locally advanced (LA) and metastatic PDNEC usually follows treatments used in pulmonary neuroendocrine carcinomas because of the similarities with small cell lung cancer. The role of surgery in PDNEC is still debated and the benefit of chemoradiotherapy (CRT) is unknown. This report summarises the experiences of CRT application in anorectal PDNEC in a single Danish institution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All patients with PDNEC treated with concomitant CRT between May 2019 and January 2021 at a University hospital in Denmark were evaluated. Demographics, treatment and survival outcomes were collected and analysed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Six patients were identified. Five patients received radiotherapy with 50.4\u00a0Gy\/28 fractions, and four were eligible for curative resection after the CRT. Distant metastasis was observed in four patients at diagnosis. Two patients with synchronous liver metastases were treated with RFA, and one received a liver resection. The treatment was well tolerated with limited side effects. The median follow-up time was 17\u00a0months (range 10\u201336\u00a0months), and the median duration of response was 11.2\u00a0months (range 8.1 to 24.2\u00a0months). One patient achieved a complete response.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A multimodal treatment approach with CRT in advanced stages of PDNEC in a highly selected patient group is well tolerated and with a high chance of achieving local control and, combined with surgery, even complete response in a single case.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-05635-3","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T18:01:51Z","timestamp":1709748111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of poorly differentiated neuroendocrine carcinomas of rectum and anus with chemoradiotherapy: a single-centre evaluation"],"prefix":"10.1007","volume":"150","author":[{"given":"Louise Elkj\u00e6r","family":"Fl\u00f8e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninna","family":"Aggerholm-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizaveta Mitkina","family":"Tabaksblat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"issue":"7","key":"5635_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1634\/theoncologist.2018-0382","volume":"24","author":"OB Alese","year":"2019","unstructured":"Alese OB, Jiang R, Shaib W, Wu C, Akce M, Behera M et al (2019) High-grade gastrointestinal neuroendocrine carcinoma management and outcomes: a national cancer database study. Oncologist 24(7):911\u2013920","journal-title":"Oncologist"},{"key":"5635_CR2","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-2-4","author":"G Antelo","year":"2020","unstructured":"Antelo G, Hierro C, Fern\u00e1ndez JP, Baena E, Bug\u00e9s C, Layos L et al (2020) Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents. Drugs Context. https:\/\/doi.org\/10.7573\/dic.2020-2-4","journal-title":"Drugs Context"},{"issue":"42","key":"5635_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001864","volume":"94","author":"B Brieau","year":"2015","unstructured":"Brieau B, Lep\u00e8re C, Walter T, Lecomte T, Guimbaud R, Manfredi S et al (2015) Radiochemotherapy versus surgery in nonmetastatic anorectal neuroendocrine carcinoma: a multicenter study by the Association des Gastro-Ent\u00e9rologues Oncologues. Medicine 94(42):e1864","journal-title":"Medicine"},{"key":"5635_CR4","doi-asserted-by":"publisher","first-page":"175883592211331","DOI":"10.1177\/17588359221133171","volume":"14","author":"LB Callesen","year":"2022","unstructured":"Callesen LB, Takacova T, Hamfjord J, W\u00fcrschmidt F, Oldhafer KJ, Br\u00fcning R et al (2022) Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis. Ther Adv Med Oncol 14:17588359221133172","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"5635_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00384-020-03809-2","volume":"36","author":"Y Chen","year":"2021","unstructured":"Chen Y, Tu J, Zhou S, Fu J, Wang Q (2021) Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the surveillance, epidemiology, and end results (SEER) database. Int J Colorectal Dis 36(4):745\u2013756","journal-title":"Int J Colorectal Dis"},{"issue":"3\u20134","key":"5635_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000503833","volume":"110","author":"G Dam","year":"2020","unstructured":"Dam G, Gr\u00f8nb\u00e6k H, Sorbye H, Thiis Evensen E, Paulsson B, Sundin A et al (2020) Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small-intestinal, and unknown primary neuroendocrine tumors. Neuroendocrinology 110(3\u20134):217\u2013224","journal-title":"Neuroendocrinology"},{"issue":"4","key":"5635_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/cncr.31124","volume":"124","author":"A Dasari","year":"2018","unstructured":"Dasari A, Mehta K, Byers LA, Sorbye H, Yao JC (2018) Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases. Cancer 124(4):807\u2013815","journal-title":"Cancer"},{"issue":"4","key":"5635_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/oncolo\/oyab039","volume":"27","author":"A Dasari","year":"2022","unstructured":"Dasari A, Shen C, Devabhaktuni A, Nighot R, Sorbye H (2022) Survival according to primary tumor location, stage, and treatment patterns in locoregional gastroenteropancreatic high-grade neuroendocrine carcinomas. Oncologist 27(4):299\u2013306","journal-title":"Oncologist"},{"issue":"6","key":"5635_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5306\/wjco.v12.i6.500","volume":"12","author":"S Della Torre","year":"2021","unstructured":"Della Torre S, de Nucci G, Lombardi PM, Grandi S, Manes G, Bollina R (2021) Long-term complete response in metastatic poorly-differentiated neuroendocrine rectal carcinoma with a multimodal approach: a case report. World J Clin Oncol 12(6):500\u2013506","journal-title":"World J Clin Oncol"},{"issue":"4","key":"5635_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1245\/s10434-019-07203-3","volume":"26","author":"AC Fields","year":"2019","unstructured":"Fields AC, Lu P, Vierra BM, Hu F, Irani J, Bleday R et al (2019) Survival in patients with high-grade colorectal neuroendocrine carcinomas: the role of surgery and chemotherapy. Ann Surg Oncol 26(4):1127\u20131133","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"5635_CR11","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.ejso.2017.04.010","volume":"43","author":"RB Galleberg","year":"2017","unstructured":"Galleberg RB, Knigge U, Tiensuu Janson E, Vestermark LW, Haugvik SP, Ladekarl M et al (2017) Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas. Eur J Surg Oncol 43(9):1682\u20131689","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"5635_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000443172","volume":"103","author":"R Garcia-Carbonero","year":"2016","unstructured":"Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B et al (2016) ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology 103(2):186\u2013194","journal-title":"Neuroendocrinology"},{"issue":"6","key":"5635_CR13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s11864-022-00969-x","volume":"23","author":"P Holmager","year":"2022","unstructured":"Holmager P, Langer SW, Kjaer A, Ringholm L, Garbyal RS, Pommergaard HC et al (2022) Surgery in patients with gastro-entero-pancreatic neuroendocrine carcinomas, neuroendocrine tumors G3 and high grade mixed neuroendocrine-non-neuroendocrine neoplasms. Curr Treat Options Oncol 23(6):806\u2013817","journal-title":"Curr Treat Options Oncol"},{"key":"5635_CR14","volume":"2012","author":"SK Jabbour","year":"2012","unstructured":"Jabbour SK, Patel S, Herman JM, Wild A, Nagda SN, Altoos T et al (2012) Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits. Int J Surg Oncol 2012:891067","journal-title":"Int J Surg Oncol"},{"issue":"7","key":"5635_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/0284186X.2021.1921262","volume":"60","author":"ET Janson","year":"2021","unstructured":"Janson ET, Knigge U, Dam G, Federspiel B, Gronbaek H, Stalberg P et al (2021) Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol 60(7):931\u2013941","journal-title":"Acta Oncol"},{"issue":"12","key":"5635_CR16","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.3390\/cancers12123545","volume":"12","author":"N Joharatnam-Hogan","year":"2020","unstructured":"Joharatnam-Hogan N, Wilson W, Shiu KK, Fusai GK, Davidson B, Hochhauser D et al (2020) Multimodal treatment in metastatic colorectal cancer (mCRC) improves outcomes\u2014the University College London Hospital (UCLH) experience. Cancers 12(12):3545","journal-title":"Cancers"},{"issue":"6","key":"5635_CR17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/0284186X.2021.1903077","volume":"60","author":"IT Laenkholm","year":"2021","unstructured":"Laenkholm IT, Langer SW, Andreassen M, Holmager P, Kjaer A, Klose M et al (2021) A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN). Acta Oncol 60(6):808\u2013812","journal-title":"Acta Oncol"},{"issue":"1","key":"5635_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12957-021-02251-0","volume":"19","author":"H Lin","year":"2021","unstructured":"Lin H, Wang L, Zhong X, Zhang X, Shao L, Wu J (2021) Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer. World J Surg Oncol 19(1):141","journal-title":"World J Surg Oncol"},{"issue":"5","key":"5635_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1245\/s10434-019-08049-5","volume":"27","author":"E Merola","year":"2020","unstructured":"Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollar A et al (2020) Surgery with radical intent: is there an indication for G3 neuroendocrine neoplasms? Ann Surg Oncol 27(5):1348\u20131355","journal-title":"Ann Surg Oncol"},{"key":"5635_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13014-015-0411-y","volume":"10","author":"AS Modrek","year":"2015","unstructured":"Modrek AS, Hsu HC, Leichman CG, Du KL (2015) Radiation therapy improves survival in rectal small cell cancer\u2014analysis of surveillance epidemiology and end results (SEER) data. Radiat Oncol 10:101","journal-title":"Radiat Oncol"},{"issue":"2","key":"5635_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2019","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA; WHO Classification of Tumours Editorial Board. The  2019 WHO classification of tumours of the digestive system. Histopathol 76(2):182\u2013188. https:\/\/doi.org\/10.1111\/his.13975. (PMID: 31433515; PMCID: PMC7003895)","journal-title":"Histopathol"},{"key":"5635_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000502825","volume":"110","author":"A Pellat","year":"2019","unstructured":"Pellat A, Walter T, Augustin J, Hautefeuille V, Hentic O, Do Cao C, Li\u00e8vre A, Coriat R, Hammel P, Dubreuil O et al (2019) Chemotherapy in resected neuroendocrine carcinomas of the digestive tract: a national study from the French group of endocrine tumours (GTE). Neuroendocrinology 110:404\u2013412. https:\/\/doi.org\/10.1159\/000502825","journal-title":"Neuroendocrinology"},{"issue":"5","key":"5635_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12967","volume":"33","author":"HC Pommergaard","year":"2021","unstructured":"Pommergaard HC, Nielsen K, Sorbye H, Federspiel B, Tabaksblat EM, Vestermark LW et al (2021) Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms. J Neuroendocrinol 33(5):e12967","journal-title":"J Neuroendocrinol"},{"key":"5635_CR23","first-page":"1","volume":"2","author":"E Qasem","year":"2016","unstructured":"Qasem E, Nangalia M, Jones H et al (2016) Small cell carcinoma of the rectum, a systematic literature review and case series. Colorectal Cancer 2:1","journal-title":"Colorectal Cancer"},{"issue":"3","key":"5635_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/DCR.0000000000000298","volume":"58","author":"H Shafqat","year":"2015","unstructured":"Shafqat H, Ali S, Salhab M, Olszewski AJ (2015) Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis. Dis Colon Rectum 58(3):294\u2013303","journal-title":"Dis Colon Rectum"},{"key":"5635_CR25","doi-asserted-by":"publisher","first-page":"204201882093830","DOI":"10.1177\/2042018820938304","volume":"11","author":"H Shi","year":"2020","unstructured":"Shi H, Qi C, Meng L, Yao H, Jiang C, Fan M et al (2020) Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A SEER database analysis of 12,878 cases. Ther Adv Endocrinol Metab 11:2042018820938304","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"9","key":"5635_CR26","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1245\/s10434-014-3725-3","volume":"21","author":"JD Smith","year":"2014","unstructured":"Smith JD, Reidy DL, Goodman KA, Shia J, Nash GM (2014) A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum. Ann Surg Oncol 21(9):2956\u20132962","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5635_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/annonc\/mds276","volume":"24","author":"H Sorbye","year":"2013","unstructured":"Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P et al (2013) Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol 24(1):152\u2013160","journal-title":"Ann Oncol"},{"issue":"3","key":"5635_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13249","volume":"35","author":"H Sorbye","year":"2023","unstructured":"Sorbye H, Grande E, Pavel M, Tesselaar M, Fazio N, Reed NS et al (2023) European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma. J Neuroendocrinol 35(3):e13249","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"5635_CR29","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.clcc.2020.12.001","volume":"20","author":"BE Ueberroth","year":"2021","unstructured":"Ueberroth BE, Liu AJ, Starr JS, Hobday TJ, Ashman JB, Mishra N et al (2021) Neuroendocrine carcinoma of the anus and rectum: patient characteristics and treatment options. Clin Colorectal Cancer 20(2):e139\u2013e149","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"5635_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/COC.0000000000000211","volume":"40","author":"KR Voong","year":"2017","unstructured":"Voong KR, Rashid A, Crane CH, Minsky BD, Krishnan S, Yao JC et al (2017) Chemoradiation for high-grade neuroendocrine carcinoma of the rectum and anal canal. Am J Clin Oncol 40(6):555\u2013560","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"5635_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/PAS.0000000000001602","volume":"45","author":"M Vyas","year":"2021","unstructured":"Vyas M, Tang LH, Rekhtman N, Klimstra DS (2021) Alterations in Ki67 labeling following treatment of poorly differentiated neuroendocrine carcinomas: a potential diagnostic pitfall. Am J Surg Pathol 45(1):25\u201334","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05635-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05635-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05635-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T11:03:18Z","timestamp":1713006198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05635-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["5635"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05635-3","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"10 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no declaration of interest or conflicts to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"114"}}